In this episode, Dr. Mahnia Madan and I discuss the challenges of managing glaucoma and dry eye conditions. We explore the impact of glaucoma medications on dry eyes, the importance of tailored treatment plans, cyclosporines, lid hygiene, in-office therapies like IPL, and the collaborative approach between optometrists and ophthalmologists. The discussion emphasizes the need for personalized care to improve patients' quality of life.
All content for Talking About Glaucoma (AAC) is the property of Robert M Schertzer, MD, MEd, FRCSC and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, Dr. Mahnia Madan and I discuss the challenges of managing glaucoma and dry eye conditions. We explore the impact of glaucoma medications on dry eyes, the importance of tailored treatment plans, cyclosporines, lid hygiene, in-office therapies like IPL, and the collaborative approach between optometrists and ophthalmologists. The discussion emphasizes the need for personalized care to improve patients' quality of life.
Ep 31 Talking About Glaucoma - 6Jun2019 LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (AAC)
Talking About Glaucoma (AAC)
12 minutes 13 seconds
6 years ago
Ep 31 Talking About Glaucoma - 6Jun2019 LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (AAC)
The goal of the late Dave Epstein was to find a drug that treats the cause of glaucoma by improving trabecular meshwork outflow. After many years of trying, Aerie Pharmaceuticals was formed and refined a Rho Kinase inhibitor called Netarsudil. In April 2018 this came to market as Rhopressa and March 2019, combined with latanoprost, as Roclatan. Today I’m talking with Rick Lewis, a glaucoma colleague based in Sacramento and Chief Medical Officer for Aerie Pharmaceuticals.
Talking About Glaucoma (AAC)
In this episode, Dr. Mahnia Madan and I discuss the challenges of managing glaucoma and dry eye conditions. We explore the impact of glaucoma medications on dry eyes, the importance of tailored treatment plans, cyclosporines, lid hygiene, in-office therapies like IPL, and the collaborative approach between optometrists and ophthalmologists. The discussion emphasizes the need for personalized care to improve patients' quality of life.
